Fundraising Fox

Ahren

Venture capital

Cambridge · 3 people tracked

Find your way into Ahren

38 people in our graph share verified history with the Ahren team — schools, employers, funds. One of them is your warm intro.

Fox Verdict
Sign up to see your fit

Fund manager profile

Ahren is a venture fund manager based in Cambridge. SEC filings show 1 venture fund on record, most recently Ahren II LP filed May 2024.

Source: SEC EDGAR Form D filings. Firm website data not yet available.

HQ
Cambridge
Founded
2022
Tracked investments
3

Team · 3 people

from public directories
Alice Newcombe-Ellis· General Partnerin
James Peter Lourensz· General Partner
Mark Douglas· General Partner

What they invest in

from 3 of 3 portfolio companies

Biotech ×2Deep Tech ×2AI & Machine Learning ×1Healthtech ×1Logistics & Supply Chain ×1New Materials ×1Robotics ×1

Investments · 3 tracked

founders shown can be your intro path

By year:2024 · 12018 · 12 dated

Ambi Roboticsambirobotics.comin𝕏

Ambi Robotics builds AI-powered robotic systems for parcel sorting and warehouse operations, addressing supply chain and logistics challenges.

AI & Machine LearningLogistics & Supply ChainRobotics

Stephen McKinley(Founder)inMatthew Matl(Founder)in

Co-investorsAhren Innovation CapitalBerkeley SkyDeck FundBow CapitalVertex VenturesTiger Global Management

Cambridge Epigenetixcambridge-epigenetix.comin𝕏Apr 2018

The company develops a 6-base sequencing platform (duet evoC) that simultaneously profiles methylation (5mC, 5hmC), genetic variants, and fragmentomics from a single cfDNA sample.

BiotechDeep TechHealthtechCambridge

Jason Mellad(Executive Officer, Director)inMartin Murphy(Director)Bobby Yerramilli-Rao(Director)Somasundaram Subramaniam(Director)Timothy Rink(Director)Thomas Hulme(Director)

Co-investorsThird Point VenturesAhren Innovation CapitalGV (Google Ventures)New Science VenturesSequoia CapitalTemasek+1 more

Constructive Bioconstructive.bioin𝕏Sep 2024

Constructive Bio is a biotechnology company that rewrites the genetic code to give cells access to non-canonical amino acid building blocks, expanding the range of proteins that can be designed, engineered, and manufactured.

BiotechDeep TechNew Materials

Jason Chin(Professor)

Co-investors+ND CapitalAmadeus Capital PartnersFine Structures VenturesGENERAL INCEPTIONLongeVCOMX Ventures+2 more

Portfolio news

latest coverage across their companies

Frequently asked questions

Where is Ahren located?
Ahren is headquartered in Cambridge.

Featured in lists